205 related articles for article (PubMed ID: 22527344)
21. Population pharmacokinetic study of cyclosporine based on NONMEM in Chinese liver transplant recipients.
Sun B; Li XY; Gao JW; Rui JZ; Guo YK; Peng ZH; Liu GL
Ther Drug Monit; 2010 Dec; 32(6):715-22. PubMed ID: 21068646
[TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.
Kassir N; Labbé L; Delaloye JR; Mouksassi MS; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Théorêt Y; Litalien C
Br J Clin Pharmacol; 2014 Jun; 77(6):1051-63. PubMed ID: 24977292
[TBL] [Abstract][Full Text] [Related]
23. Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.
Bourgoin H; Paintaud G; Büchler M; Lebranchu Y; Autret-Leca E; Mentré F; Le Guellec C
Br J Clin Pharmacol; 2005 Jan; 59(1):18-27. PubMed ID: 15606436
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data.
Srinivas NR
Biopharm Drug Dispos; 2015 Dec; 36(9):575-86. PubMed ID: 26224332
[TBL] [Abstract][Full Text] [Related]
25. Bayesian Networks: A New Approach to Predict Therapeutic Range Achievement of Initial Cyclosporine Blood Concentration After Pediatric Hematopoietic Stem Cell Transplantation.
Leclerc V; Ducher M; Bleyzac N
Drugs R D; 2018 Mar; 18(1):67-75. PubMed ID: 29404858
[TBL] [Abstract][Full Text] [Related]
26. Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.
Monchaud C; Rousseau A; Leger F; David OJ; Debord J; Dantoine T; Marquet P
Eur J Clin Pharmacol; 2003 Apr; 58(12):813-20. PubMed ID: 12698308
[TBL] [Abstract][Full Text] [Related]
27. Prediction of area under the cyclosporine concentration versus time curve in children undergoing hematopoietic stem cell transplantation.
Dupuis LL; Seto W; Teuffel O; Gibson P; Schultz KR; Doyle JD; Gassas A; Egeler RM; Sung L; Schechter T
Biol Blood Marrow Transplant; 2013 Mar; 19(3):418-23. PubMed ID: 23128321
[TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetic study of cyclosporine in the hematopoietic stem cell transplant recipients.
Zhou Y; Sheng XY; Xu JY; Bi SS; Lu W; Cui YM
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):568-75. PubMed ID: 23611568
[TBL] [Abstract][Full Text] [Related]
29. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
Canadian Neoral Renal Transplantation Study Group
Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
[TBL] [Abstract][Full Text] [Related]
30. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.
de Winter BC; Monchaud C; Prémaud A; Pison C; Kessler R; Reynaud-Gaubert M; Dromer C; Stern M; Guillemain R; Knoop C; Estenne M; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Jan; 51(1):29-39. PubMed ID: 22054177
[TBL] [Abstract][Full Text] [Related]
31. A population pharmacokinetic model of cyclosporine in the early postoperative phase in patients with liver transplants, and its predictive performance with Bayesian fitting.
Charpiat B; Falconi I; Bréant V; Jelliffe RW; Sab JM; Ducerf C; Fourcade N; Thomasson A; Baulieux J
Ther Drug Monit; 1998 Apr; 20(2):158-64. PubMed ID: 9558129
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of cyclosporine A at a high-peak concentration of twice-daily infusion and oral administration in allogeneic haematopoietic stem cell transplantation.
Inoue Y; Saito T; Ogawa K; Nishio Y; Kosugi S; Suzuki Y; Shibuya Y; Kato M; Takahashi M; Miura I
J Clin Pharm Ther; 2011 Aug; 36(4):518-24. PubMed ID: 21105879
[TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
Xue L; Zhang WW; Ding XL; Zhang JJ; Bao JA; Miao LY
Am J Med Sci; 2014 Dec; 348(6):448-54. PubMed ID: 25247760
[TBL] [Abstract][Full Text] [Related]
34. A compartmental pharmacokinetic model of cyclosporin and its predictive performance after Bayesian estimation in kidney and simultaneous pancreas-kidney transplant recipients.
Cremers SC; Scholten EM; Schoemaker RC; Lentjes EG; Vermeij P; Paul LC; den Hartigh J; de Fijter JW
Nephrol Dial Transplant; 2003 Jun; 18(6):1201-8. PubMed ID: 12748356
[TBL] [Abstract][Full Text] [Related]
35. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis.
Kim IW; Yun HY; Choi B; Han N; Park SY; Lee ES; Oh JM
Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246
[TBL] [Abstract][Full Text] [Related]
36. External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.
Mao JJ; Jiao Z; Yun HY; Zhao CY; Chen HC; Qiu XY; Zhong MK
Br J Clin Pharmacol; 2018 Jan; 84(1):153-171. PubMed ID: 28891596
[TBL] [Abstract][Full Text] [Related]
37. A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients.
Falck P; Midtvedt K; Vân Lê TT; Storehagen L; Holdaas H; Hartmann A; Asberg A
Clin Pharmacokinet; 2009; 48(9):615-23. PubMed ID: 19725595
[TBL] [Abstract][Full Text] [Related]
38. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
Brooks E; Tett SE; Isbel NM; Staatz CE
Clin Pharmacokinet; 2016 Nov; 55(11):1295-1335. PubMed ID: 27138787
[TBL] [Abstract][Full Text] [Related]
39. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
[TBL] [Abstract][Full Text] [Related]
40. A limited sampling strategy for the estimation of 12-hour Neoral systemic drug exposure in heart transplant recipients.
Balram C; Sivathasan C; Cheung YB; Tan SB; Tan YS
J Heart Lung Transplant; 2002 Sep; 21(9):1016-21. PubMed ID: 12231373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
